Status:
UNKNOWN
Leukemic Phase of ALCL
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Anaplastic Lymphoma
Eligibility:
All Genders
9+ years
Brief Summary
Collecting data about the rare leukemic presentation of anaplastic lymphoma to study the characteristics of patients with leukemic phase of ALCL
Eligibility Criteria
Inclusion
- Patients presenting a leukemic phase of anaplastic lymphoma
Exclusion
- None
Key Trial Info
Start Date :
January 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 13 2021
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04908059
Start Date
January 27 2021
End Date
July 13 2021
Last Update
July 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hematology Laboratory - Strasbourg University Hospitals
Strasbourg, France, 67091